The Global Neurodiagnostics Market was valued at $6,530 million in 2020, and is projected to reach $12,899 million by 2028, registering a CAGR of 7% from 2022 to 2028.
Neurodiagnostics is a test performed to diagnose problems with the human brain, nervous system, and sleep habits. There are two types of neurodiagnostic tests: imaging tests or scans (eg x-rays, CT scans, MRI scans, PET scans) and electric shock detection (eg EEG, EMG). Neurodiagnostic testing can be performed as part of a neurological examination that includes monitoring and analysis of the nervous system, which can effectively initiate a treatment procedure.
(Get 15% Discount on Buying this Report)
A full report of Global Neurodiagnostics Market is available at: https://orionmarketreports.com/neurodiagnostics-market/104917/
Market Segments
By Product
- Diagnostic & Imaging Systems
- Electroencephalogram (EEG) Systems
- Magnetic Resonance Imaging (MRI) Systems
- Ultrasound Imaging Systems
- Computed Tomography (CT) Scanner
- Others
- In-vitro diagnostics (IVD)
- Molecular Diagnostics
- Other IVDs
By Condition
- Neuro Degenerative Diseases
- Epilepsy
- Stroke
- Headache Disorders
- Sleep Disorders
- Others
Key Players
Some of the companies which are currently dominating the market are GE Healthcare, Siemens Healthineers, Philips Healthcare, Thermo Fisher Scientific, Inc, Hitachi, Ltd, Natus Medical Incorporated, Lifelines Neuro Company, Advanced Brain Monitoring, Inc and Nihon Kohden Corporation.
Scope of the Report
The research study analyzes the global Neurodiagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Neurodiagnostics Market Report
1. What was the Neurodiagnostics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Neurodiagnostics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Neurodiagnostics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Neurodiagnostics market.
- The market share of the global Neurodiagnostics market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Neurodiagnostics market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Neurodiagnostics market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
